inflammatory bowel disease
Australia's Colonial Foundation Commits A$21M for Inflammatory Disease Dx Research Center
The new center will use spatial omics technology and be led by the Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research (WEHI).
Geneoscopy, Adiso Therapeutics Partner to Advance Inflammatory Bowel Disease Therapy
Adiso will use Geneoscopy's stool-based RNA platform to assess patient response to its candidate IBD therapy in a Phase II trial.
Garvan Institute Gets A$11.6M From Australian Government to Develop Genomics-Based Disease Tests
Four teams will use genomics to improve the diagnosis and treatment of diseases including Parkinson's, inflammatory bowel disease, and rare genetic disorders.
ProciseDx Gets US Marketing Clearance for Infliximab, Adalimumab POC Monitoring Tests
The firm plans this year to launch in the US its tests used to measure drug levels in inflammatory bowel disease patients and guide treatment.
Adaptive Biotechnologies Halts T-Detect Commercialization, Reports 13 Percent Q2 Revenue Growth
Premium
The company realized it is costly to develop single-disease T-Detect assays and is deferring commercialization until a clear path to reimbursement is proven.
May 5, 2022
Mar 12, 2021
Prometheus Biosciences Prices Upsized $190M IPO
Jul 30, 2019
PredictImmune Closes £10M Series B Financing Round
Jun 28, 2019
Bühlmann Labs IBD Assay FDA Cleared
Jun 27, 2019